Basic phospholipase A2 Ceg-N6 (99-110), pCergo

General Information


DRACP ID  DRACP04259

Peptide Name   Basic phospholipase A2 Ceg-N6 (99-110), pCergo

Sequence  NLRTYKKRYMFY

Sequence Length  12

UniProt ID  Q6EER5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C79H119N21O18S

Absent amino acids  ACDEGHIPQSVW

Common amino acids  Y

Mass  187937

Pl  10.57

Basic residues  4

Acidic residues  0

Hydrophobic residues  2

Net charge  4

Boman Index  -4032

Hydrophobicity  -136.67

Aliphatic Index  32.5

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  4470

Absorbance 280nm  406.36

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34130109

Title  Dissection of phospholipases A 2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18751

DRACP is developed by Dr.Zheng's team.